One application for diagnostic otoacoustic emissions is in the use of ototoxicity monitoring. Monitoring protocols aim to assist in the identification of ototoxicity which can then inform dose changes, adjustments to treatment plans, and early rehabilitation to mitigate the effects of ototoxicity. Of the evoked family of otoacoustic emissions, distortion product OAEs (DPOAEs) lend themselves better to ototoxicity monitoring than transient evoked OAEs (TEOAEs).